0001744333-22-000001.txt : 20220929 0001744333-22-000001.hdr.sgml : 20220929 20220928190939 ACCESSION NUMBER: 0001744333-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220929 DATE AS OF CHANGE: 20220928 EFFECTIVENESS DATE: 20220929 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELIXIRGEN THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001744333 IRS NUMBER: 830534578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460209 FILM NUMBER: 221277437 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 624 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 443-451-5300 MAIL ADDRESS: STREET 1: 855 N. WOLFE ST. STREET 2: SUITE 624 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001744333 ELIXIRGEN THERAPEUTICS, INC. 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 443-451-5300 DELAWARE Elixirgen Therapeutics, LLC None Corporation true Akihiro Ko 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Executive Officer Director Promoter Minoru Ko 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Executive Officer Director Maiko Katadae 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Hiroaki Kobayashi 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Shauna Callahan 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Thomas White 855 N. Wolfe Street, Suite 624 Baltimore MD MARYLAND 21205 Director Biotechnology Decline to Disclose 06b false 2022-09-14 false true false 0 5000000 5000000 0 false 1 0 0 0 false ELIXIRGEN THERAPEUTICS, INC. /s/ Akihiro Ko Akihiro Ko Chief Executive Officer 2022-09-28